These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 21113514)
21. Chemical Editing of Macrocyclic Natural Products and Kinetic Profiling Reveal Slow, Tight-Binding Histone Deacetylase Inhibitors with Picomolar Affinities. Kitir B; Maolanon AR; Ohm RG; Colaço AR; Fristrup P; Madsen AS; Olsen CA Biochemistry; 2017 Sep; 56(38):5134-5146. PubMed ID: 28858522 [TBL] [Abstract][Full Text] [Related]
22. From natural products to HDAC inhibitors: An overview of drug discovery and design strategy. Qiu X; Zhu L; Wang H; Tan Y; Yang Z; Yang L; Wan L Bioorg Med Chem; 2021 Dec; 52():116510. PubMed ID: 34826681 [TBL] [Abstract][Full Text] [Related]
23. Optimization and mechanistic studies of psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). Nicolaou KC; Hughes R; Pfefferkorn JA; Barluenga S Chemistry; 2001 Oct; 7(19):4296-310. PubMed ID: 11686610 [TBL] [Abstract][Full Text] [Related]
24. Natural products as zinc-dependent histone deacetylase inhibitors. Tan S; Liu ZP ChemMedChem; 2015 Mar; 10(3):441-50. PubMed ID: 25581683 [TBL] [Abstract][Full Text] [Related]
25. Parallel synthesis of a bis-triazoles library as psammaplin A analogues: A new wave of antibiofilm compounds? Andjouh S; Blache Y Bioorg Med Chem Lett; 2019 Feb; 29(4):614-618. PubMed ID: 30600205 [TBL] [Abstract][Full Text] [Related]
26. Triggering of Suicidal Erythrocyte Death by Psammaplin A. Al Mamun Bhuyan A; Signoretto E; Lang F Cell Physiol Biochem; 2016; 39(3):908-18. PubMed ID: 27497787 [TBL] [Abstract][Full Text] [Related]
27. Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. McCulloch MW; Coombs GS; Banerjee N; Bugni TS; Cannon KM; Harper MK; Veltri CA; Virshup DM; Ireland CM Bioorg Med Chem; 2009 Mar; 17(6):2189-98. PubMed ID: 19022675 [TBL] [Abstract][Full Text] [Related]
28. The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors. Chen J; Jiang CS; Ma WQ; Gao LX; Gong JX; Li JY; Li J; Guo YW Bioorg Med Chem Lett; 2013 Sep; 23(18):5061-5. PubMed ID: 23942421 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of tyrosine-based hydroxamic acid analogs as novel histone deacetylases (HDACs) inhibitors. Zhang Y; Feng J; Liu C; Fang H; Xu W Bioorg Med Chem; 2011 Aug; 19(15):4437-44. PubMed ID: 21733698 [TBL] [Abstract][Full Text] [Related]
30. Biochemical and Anti-Triple Negative Metastatic Breast Tumor Cell Properties of Psammaplins. Zhou YD; Li J; Du L; Mahdi F; Le TP; Chen WL; Swanson SM; Watabe K; Nagle DG Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30423844 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of piperamide analogues as HDAC inhibitors. Luo Y; Liu HM; Su MB; Sheng L; Zhou YB; Li J; Lu W Bioorg Med Chem Lett; 2011 Aug; 21(16):4844-6. PubMed ID: 21745740 [TBL] [Abstract][Full Text] [Related]
32. Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products. Richard K; Williams DE; de Silva ED; Brockman MA; Brumme ZL; Andersen RJ; Tietjen I Viruses; 2018 Jun; 10(7):. PubMed ID: 29954099 [TBL] [Abstract][Full Text] [Related]
33. Antiparasitic Activity of Bromotyrosine Alkaloids and New Analogues Isolated from the Fijian Marine Sponge Aplysinella rhax. Oluwabusola ET; Tabudravu JN; Al Maqbali KS; Annang F; Pérez-Moreno G; Reyes F; Jaspars M Chem Biodivers; 2020 Oct; 17(10):e2000335. PubMed ID: 32697400 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and tissue distribution of psammaplin A, a novel anticancer agent, in mice. Kim HJ; Kim TH; Seo WS; Yoo SD; Kim IH; Joo SH; Shin S; Park ES; Ma ES; Shin BS Arch Pharm Res; 2012 Oct; 35(10):1849-54. PubMed ID: 23139138 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and Investigation of Therapeutic Potential of Isoform-Specific HDAC8 Inhibitors for the Treatment of Cutaneous T Cell Lymphoma. Umamaheswari A; Puratchikody A; Hari N Anticancer Agents Med Chem; 2019; 19(7):916-934. PubMed ID: 30836926 [TBL] [Abstract][Full Text] [Related]
36. HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors. Sangwan R; Rajan R; Mandal PK Eur J Med Chem; 2018 Oct; 158():620-706. PubMed ID: 30245394 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and antibacterial activities of marine natural product ianthelliformisamines and subereamine synthetic analogues. Khadake SN; Karamathulla S; Jena TK; Monisha M; Tuti NK; Khan FA; Anindya R Bioorg Med Chem Lett; 2021 May; 39():127883. PubMed ID: 33662536 [TBL] [Abstract][Full Text] [Related]
38. [Synthetic Study on Bicyclic Depsipeptides Containing an Intramolecular Disulfide Bond]. Narita K Yakugaku Zasshi; 2022; 142(9):917-926. PubMed ID: 36047217 [TBL] [Abstract][Full Text] [Related]
39. Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors. Reddy DN; Ballante F; Chuang T; Pirolli A; Marrocco B; Marshall GR J Med Chem; 2016 Feb; 59(4):1613-33. PubMed ID: 26681404 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors. De Vreese R; D'hooghe M Eur J Med Chem; 2017 Jul; 135():174-195. PubMed ID: 28453994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]